Common Contracts
14 similar Form of Release Agreement contracts by Alumis Inc.
January 12, 2022Form of Release Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of General Counsel of Alumis Inc. (the “Company”),. This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ESKER THERAPEUTICS, INC. September 15, 2021Form of Release Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of Chief Business Officer and General Counsel of Esker Therapeutics, Inc. (the “Company”), a Foresite Labs, LLC (“Foresite Labs”) incubated company. This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ContractForm of Release Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant customarily and actually treats as private or confidential.
ESKER THERAPEUTICS, INC. September 15, 2021Form of Release Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of President, Chief Executive Officer and Chairman of the Board of Esker Therapeutics, Inc. (the “Company”), a Foresite Labs, LLC (“Foresite Labs”) incubated company. This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
March 22, 2022Form of Release Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of Chief Financial Officer of Alumis Inc. (the “Company”). This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ESKER THERAPEUTICS, INC. September 15, 2021Form of Release Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of Chief Scientific Officer of Esker Therapeutics, Inc. (the “Company”), a Foresite Labs, LLC (“Foresite Labs”) incubated company. This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ESKER THERAPEUTICS, INC. November 12, 2021Form of Release Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of Vice President, Program Management of Esker Therapeutics, Inc. (the “Company”). This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the Company’s business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ESKER THERAPEUTICS, INC. November 12, 2021Form of Release Agreement • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of Vice President, Program Management of Esker Therapeutics, Inc. (the “Company”). This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the Company’s business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ESKER THERAPEUTICS, INC. September 15, 2021Form of Release Agreement • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of Chief Scientific Officer of Esker Therapeutics, Inc. (the “Company”), a Foresite Labs, LLC (“Foresite Labs”) incubated company. This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ESKER THERAPEUTICS, INC. September 15, 2021Form of Release Agreement • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of President, Chief Executive Officer and Chairman of the Board of Esker Therapeutics, Inc. (the “Company”), a Foresite Labs, LLC (“Foresite Labs”) incubated company. This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ContractForm of Release Agreement • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant customarily and actually treats as private or confidential.
ESKER THERAPEUTICS, INC. September 15, 2021Form of Release Agreement • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of Chief Business Officer and General Counsel of Esker Therapeutics, Inc. (the “Company”), a Foresite Labs, LLC (“Foresite Labs”) incubated company. This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
January 12, 2022Form of Release Agreement • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of General Counsel of Alumis Inc. (the “Company”),. This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
March 22, 2022Form of Release Agreement • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of Chief Financial Officer of Alumis Inc. (the “Company”). This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
